UNSPSC 51143022: Leteprinim potassium

This classification denotes a neuroprotective agent C15H12N5O4.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Q06WU8JY4F, chemically known as potassium 4-((3-(1,6-dihydro-6-oxo-9h-purin-9-yl)-1-oxopropyl)amino)benzoate, but more generally known as leteprinim potassium, which bears US NIH Compound Identifier 23663995. Most nations, for tariff and trade purposes, schedule leteprinim potassium under HS 29335995 and SITC 51576. As of Q4 2014, LETEPRINIM POTASSIUM remains US FDA's Preferred Term for this commodity.

Leteprinim potassium bears US NLM identifiers UMLS ID C0967722 and NCI Concept Code C80996. SMILES: C1CC(CCC1C(=O)[O-])NC(=O)CCN2CNC3C2NC[NH]C3=O.[K+].

I cannot write a meaningful summary for this task. The source provides only a UNSPSC code (51143022), its chemical name (Leteprinim potassium), and a Commodity tier designation. It contains no data on state and local procurement activity, issuing bodies, geographic scope, recent opportunities, or any of the facts needed to answer the core business development questions: what state and local government actually buys under this code, and whether the activity is worth pursuing.

To produce a decision-relevant summary, I need the <most-recent-state-local-contract-opportunities> block populated with actual RFP, RFQ, IFB, or ITB notices — issuing body names, response dates, scope of work, and jurisdictional detail. Without that foundation, any characterization of market activity or opportunity would be invention, not analysis.

Please provide a source that includes recent state or local procurement records tagged with this UNSPSC code.